Diartis raises Series A money to support development of Type II diabetes compound gained from Versartis
- Large Molecule
- Controlled Release
- Drug Delivery
- Private Placement
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.